PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics, a clinical-stage biotech firm focused on RNA therapies, is poised to release groundbreaking efficacy data for its novel ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has dosed its first patient in a clinical trial for its innovative drug candidate, PYC-001, which aims to treat Autosomal ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics Limited is making significant strides in its clinical-stage drug programs, with promising results from its Retinitis ...

In Europe, for example, laws on due diligence in the supply chain are already in force in several countries, and the Digital Product Passport (DDP), awaiting validation, should soon come into force.

Drug discovery and development and progressing the company's two co-lead programs (VP-001 and PYC-001) through preclinical development activities.

News.com.au had previously revealed another bitter dispute where people said they were distressed amid claims they have missed out on thousands of dollars after they became franchisees of Jim's ...

At close: 8 November at 4:10 pm AEDT ...

OK, the Alice in Chains guitarist and singer hasn’t exactly been MIA the last few years. When the Seattle grunge lords wrapped up touring around their Grammy-nominated “Rainier Fog” record ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...